Key Players
Competitive Landscape
Competition in Thailand medical tourism divides between large private hospital networks, single-site international hospitals and cosmetic surgery specialists. BDMS runs 60 hospitals and 9,360 beds under the Bangkok Hospital, Samitivej, Phyathai, Paolo and BNH brands. [8] Bumrungrad sells international patient care from a Bangkok hospital with 580 licensed inpatient beds. [2] Yanhee Hospital competes on cosmetic and plastic surgery through 36 treatment centres. [10] International buyers qualify hospitals on accreditation, appointment coordination and the clarity of discharge arrangements.
Source-market mix has become the main competitive test in 2026. Bumrungrad lifted international patients to 66.4% of second-quarter revenue, with revenue from Myanmar patients up 27.8% and from US patients up 19.2%. [5] BDMS recorded a 2% fall in international patient revenue after revenue from Cambodian patients fell 67% and from Middle East patients fell 24%, and its international revenue rose 10% excluding those two markets. [6] Hospitals that spread patients across several source countries, and keep capacity ready for markets that recover, are best placed to protect international revenue.
Company developments mapped to drivers, trends and opportunities (2026-2036)
| Development | Driver | Trend | Opportunity |
|---|---|---|---|
| August 2026: Bumrungrad reported international patients at 66.4% of second-quarter revenue, up from 64.4%. [5] | Patients from Myanmar and the United States are driving international growth. | Hospitals build revenue around high-acuity international patients. | Coordinated care pathways for Myanmar and US patients. |
| August 2026: BDMS reported international patient revenue down 2% in the second quarter and up 10% excluding Cambodian and Middle East patients. [6] | Regional conflict cut revenue from Cambodian and Middle East patients. | Networks rebalance towards Myanmar and US patients. | Recovering Middle East patient volumes restore growth. |
| August 2026: BDMS reported a network of 60 hospitals and 9,360 beds. [8] | Large networks absorb international demand across several brands. | Samitivej and Phyathai operate within the BDMS network. | Network-wide international patient services across Bangkok and regional hospitals. |
| January 2026: The Tourism Authority of Thailand set out a value-led strategy that includes wellness and medical tourism. [1] | Government policy prioritises value over visitor numbers. | Wellbeing tourism remains a priority in the 2027 direction. [3] | Wellness-linked medical packages in destinations such as Phuket. |
Source: Future Market Insights analysis, 2026 to 2036.
Company updates confirm that the leading hospitals compete on the mix of international source markets they serve. Operators that pair coordinated patient services with capacity in Bangkok and the regions are best placed to hold revenue as individual markets move.
How are key market participants positioned in the Thailand medical tourism market?
BDMS and its Bangkok Hospital, Samitivej and Phyathai brands lead on network scale, with 60 hospitals and 9,360 beds. [8] Bumrungrad concentrates on international patients at a Bangkok hospital of 580 licensed inpatient beds and plans a Phuket hospital with 120 beds in its first phase and 212 beds ultimately. [2][9] Yanhee Hospital, with 400 inpatient beds, positions on cosmetic and plastic surgery. [10]
What qualification or purchasing requirements matter most to prospective buyers?
International patients and referral agents look for accreditation, translation, appointment coordination and clear discharge arrangements. Yanhee holds Joint Commission International accreditation, first granted in January 2011. [10] Hospitals that confirm the treatment plan, companion stay and follow-up before travel give buyers a clearer basis for choice.
Which service capabilities distinguish the leading companies?
Bumrungrad’s international patients provide 66.4% of its revenue, which shows the depth of its international service. [5] BDMS combines network scale with a spread of source markets, with international revenue up 10% excluding Cambodia and the Middle East. [6] Yanhee’s 36 treatment centres support cosmetic and plastic surgery alongside general care. [10]
How does geographic reach differ among the leading companies?
BDMS operates across Thailand and, through two Royal International hospitals, in Cambodia. [8] Bumrungrad serves patients from the Middle East, Southeast Asia and the United States from Bangkok and plans to add Phuket. [5][9] Yanhee operates from a single site in Bangkok’s Bang Phlat district. [10]
Representative Company Overview
| Company | Positioning | Verified Development |
|---|---|---|
| Bumrungrad International Hospital | Bangkok international hospital with 580 licensed inpatient beds. [2] | Reported international patients at 66.4% of second-quarter 2026 revenue and plans a Phuket hospital opening in mid-2027 with 120 beds, rising to 212, for an investment of over THB 4.3 billion. [5][9] |
| Bangkok Dusit Medical Services | Hospital network of 60 hospitals and 9,360 beds in August 2026. [8] | Reported a 2% fall in second-quarter 2026 international patient revenue and 10% growth excluding Cambodian and Middle East patients. [6] |
| Samitivej Hospital | Hospital brand within the BDMS network. [8] | Operated 7 hospitals and 1,418 beds as of August 2026. [8] |
| Phyathai Hospitals | Hospital brand within the BDMS network. [8] | Operated 8 hospitals and 1,654 beds as of August 2026. [8] |
| Yanhee Hospital | Bangkok hospital specialising in cosmetic and plastic surgery, with 400 inpatient beds. [10] | Holds Joint Commission International accreditation since January 2011 and runs 36 treatment centres. [10] |
Research Methodology
The Thailand medical tourism market assessment was conducted using primary interviews and secondary literature analysis combined with top-down data triangulation to validate market size, segment shares, and competitive positioning.
